News | Cardiovascular Ultrasound

Over the past several years, advanced heart failure patients who have not responded to medical therapy have been given new hope, and are surviving longer with implanted left ventricular assist devices (LVADs). Although echocardiography is recommended for each phase of care for patients with LVADs, there has been limited published data and no formal guidance for the use of echocardiography in this growing patient population. In an effort to fill this gap, a new document, Echocardiography in the Management of Patients with Left Ventricular Assist Devices: Recommendations from the American Society of Echocardiography, will appear in the August 2015 issue of the Journal of the American Society of Echocardiography (JASE).

Home August 04, 2015
Home
News | Antiplatelet and Anticoagulation Therapies

Triple therapy is no better than dual antiplatelet therapy in preventing major adverse cardiac events in older patients with atrial fibrillation who had a heart attack treated with angioplasty, according to a new study. The study, published in the Journal of the American College of Cardiology, also found that triple therapy resulted in more complications.

Home August 04, 2015
Home
News | Cardiovascular Business

Jeff Zagoudis, associate editor of the Scranton Gillette Communications’ Healthcare Group publications Imaging ...

Home August 04, 2015
Home
News | Cardiac Imaging

Specific cardiovascular risk factors are associated with smaller regional brain volumes that may be early indicators of Alzheimer’s disease and dementia, according to a study published online in the journal Radiology. Those factors include alcohol consumption, smoking, obesity and diabetes.

Home August 04, 2015
Home
News | Implantable Cardioverter Defibrillator (ICD)

Biotronik announced CE approval of 3 Tesla (T) magnetic resonance imaging (MRI) scanning with exclusion zone for its two latest generations of pacemakers. The company now offers both implantable cardioverter-defibrillators (ICDs) and pacemakers approved for 3T scans.

Home August 03, 2015
Home
News | Heart Failure

Sunshine Heart announced plans to commence a first-in-human study using its novel C-Pulse transcutaneous energy transmission (TET) system and a new, smaller implantable pump in quarter three 2016.

Home August 03, 2015
Home
Technology | Intravascular Imaging

Pie Medical Imaging announced the release of CAAS IntraVascular 2.0, the dedicated software for analysis of intravascular ultrasound (IVUS), near-infrared spectroscopy (NIRS)-IVUS and optical coherence tomography (OCT) datasets. This new release contains an optimized OCT analysis and the in-depth analysis of NIRS-IVUS datasets. Data can be imported easily from the console or picture archiving and communication system (PACS) into the study list, which provides a clear overview of your data. CAAS IntraVascular has U.S. Food and Drug Administration (FDA) 510(k) clearance for both IVUS and OCT.

Home August 03, 2015
Home
European interventional cardiology market, drug-eluting stents, Abbott Laboratories, Boston Scientific, Medtronic
Feature | Stents

According to a new report on the Europe market for interventional cardiology by iData Research, drug-eluting stents accounted for a significant portion of the European markets for interventional cardiology devices in 2014. The advent of drug-eluting stents has driven the interventional cardiology market beyond expectations, as these devices have managed to increase the size of the market by virtue of their relatively high average selling price (ASP). New developments in drug-eluting stents such as biodegradable materials are expected to keep the market competitive despite safety concerns regarding late stent thrombosis.

Home July 31, 2015
Home
News | Cardiovascular Ultrasound

The American Society of Echocardiography (ASE) released a new document describing various imaging strategies for diagnosing a “hole in the heart,” one of the most common types of congenital heart defects. The document, Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions, describes the various defects, the modalities used to evaluate them, and clearly lays out strategies for optimal imaging.

Home July 31, 2015
Home
News | Ultrasound Imaging

After a tornado decimated the hospital only four years ago, Mercy Hospital Joplin in Joplin, Missouri, reopened its doors in March with a new, 900,000-square-foot facility with state-of-the-art equipment. Part of the acquisition by Mercy Hospital Joplin, formerly St. John’s Regional Medical Center, included eight Aplio 300 Platinum ultrasound systems from Toshiba America Medical Systems Inc.

Home July 30, 2015
Home
News | Radiopharmaceuticals and Tracers

Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of Tc99m-tilmanocept, a Manocept platform product, to localize in high-risk atherosclerotic plaques. The study — funded through a $321,000 Phase 1 Small Business Innovation Research (SBIR) grant from the National Heart, Lung and Blood Institute (NHLBI), National Institute of Health (NIH) — will be conducted with Massachusetts General Hospital (MGH) and Harvard Medical School.

Home July 30, 2015
Home
Technology | Robotic Systems

The Magellan 10 French Robotic Catheter from Hansen Medical is indicated for use in the peripheral vasculature.

Home July 29, 2015
Home
News | Stem Cell Therapies

A new clinical trial to test how a high dose of stem cells delivered via a method called retrograde coronary sinus infusion affects end-stage heart failure patients is showing promising results. The method involves giving the cells backwards (retrograde) through the heart through the main vein (the coronary sinus).

Home July 29, 2015
Home
News | Contrast Media

Guerbet announced that it has entered into a definitive agreement under which it will acquire Mallinckrodt's contrast media and delivery systems business ("CMDS").

Home July 29, 2015
Home
News | Cardiovascular Ultrasound

Epsilon Imaging Inc. announced that several studies were presented at the American Society of Echocardiography (ASE) 2015 conference, June 13-16, on its EchoInsight automated measurement suite for improved analysis and interpretation in echo.

Home July 29, 2015
Home
Subscribe Now